Clinical trial
Induction Intensification in Treating Infants With Newly Diagnosed Acute…
NCT00002756 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002756 |
|---|---|
| Title | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia |
| Official title | Induction Intensification in Infant ALL: A Children's Oncology Group Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, leucovorin calcium, mercaptopurine, methotrexate, prednisone and 2 more |
| Enrollment | 221 |
| Start date | Jun 1, 1996 |
| Primary completion | Sep 1, 2007 |
| Completion | Mar 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 14, 2014 |
| Countries | Australia, Canada, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: